In 2006, Nobel Prize Is RNAi's Landmark; Small RNAs Expected to Mature in 2007

Fire and Mello’s Nobel Prize topped just about everyone’s list as RNAi’s defining moment in 2006, but advancements in therapeutics, Merck’s buyout of Sirna, and new clarity on the IP front prove significant, as well.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.